These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26188115)

  • 21. Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane.
    Lu Y; Rieth S; Lohitnavy M; Dennison J; El-Masri H; Barton HA; Bruckner J; Yang RS
    Regul Toxicol Pharmacol; 2008 Mar; 50(2):249-60. PubMed ID: 18226845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The margin of internal exposure (MOIE) concept for dermal risk assessment based on oral toxicity data - A case study with caffeine.
    Bessems JGM; Paini A; Gajewska M; Worth A
    Toxicology; 2017 Dec; 392():119-129. PubMed ID: 28288858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone.
    Gentry PR; Covington TR; Clewell HJ; Anderson ME
    J Toxicol Environ Health A; 2003 Dec; 66(23):2209-25. PubMed ID: 14612334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanism of ethylene glycol ether reproductive and developmental toxicity and evidence for adverse effects in humans.
    Welsch F
    Toxicol Lett; 2005 Mar; 156(1):13-28. PubMed ID: 15705484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous determination of phenoxyethanol and its major metabolite, phenoxyacetic acid, in rat biological matrices by LC-MS/MS with polarity switching: Application to ADME studies.
    Kim TH; Kim MG; Kim MG; Shin BS; Kim KB; Lee JB; Paik SH; Yoo SD
    Talanta; 2015 Nov; 144():29-38. PubMed ID: 26452788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologically-based pharmacokinetic and toxicokinetic models in cancer risk assessment.
    Krishnan K; Johanson G
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(1):31-53. PubMed ID: 16291521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds.
    Pelekis M; Gephart LA; Lerman SE
    Regul Toxicol Pharmacol; 2001 Feb; 33(1):12-20. PubMed ID: 11259175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative risk analysis for N-methyl pyrrolidone using physiologically based pharmacokinetic and benchmark dose modeling.
    Poet TS; Kirman CR; Bader M; van Thriel C; Gargas ML; Hinderliter PM
    Toxicol Sci; 2010 Feb; 113(2):468-82. PubMed ID: 19875680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration.
    Gentry PR; Covington TR; Andersen ME; Clewell HJ
    Regul Toxicol Pharmacol; 2002 Aug; 36(1):51-68. PubMed ID: 12383718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Final report on the safety assessment of methoxyisopropanol and methoxyisopropyl acetate as used in cosmetics.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 2():25-39. PubMed ID: 18830862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidone.
    Poet TS; Schlosser PM; Rodriguez CE; Parod RJ; Rodwell DE; Kirman CR
    Regul Toxicol Pharmacol; 2016 Apr; 76():102-12. PubMed ID: 26776754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients.
    Gajewska M; Worth A; Urani C; Briesen H; Schramm KW
    Toxicol Lett; 2014 Jun; 227(3):189-202. PubMed ID: 24731971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically based mathematical model.
    Clarke DO; Elswick BA; Welsch F; Conolly RB
    Toxicol Appl Pharmacol; 1993 Aug; 121(2):239-52. PubMed ID: 8346541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refinement of the oral exposure description in the cyclic siloxane PBPK model for rats and humans: Implications for exposure assessment.
    Campbell JL; Andersen ME; Van Landingham C; Gentry R; Jensen E; Domoradzki JY; Clewell HJ
    Toxicol Lett; 2017 Oct; 279 Suppl 1():125-135. PubMed ID: 28408153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a physiologically based pharmacokinetic (PBPK) model for methyl iodide in rats, rabbits, and humans.
    Sweeney LM; Kirman CR; Gannon SA; Thrall KD; Gargas ML; Kinzell JH
    Inhal Toxicol; 2009 May; 21(6):552-82. PubMed ID: 19519155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the non-cancer risk for RDX (hexahydro-1,3,5-trinitro-1,3,5-triazine) using physiologically based pharmacokinetic (PBPK) modeling.
    Sweeney LM; Gut CP; Gargas ML; Reddy G; Williams LR; Johnson MS
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):107-14. PubMed ID: 22197625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probabilistic framework for the estimation of the adult and child toxicokinetic intraspecies uncertainty factors.
    Pelekis M; Nicolich MJ; Gauthier JS
    Risk Anal; 2003 Dec; 23(6):1239-55. PubMed ID: 14641898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steady-state solutions to PBPK models and their applications to risk assessment I: Route-to-route extrapolation of volatile chemicals.
    Chiu WA; White P
    Risk Anal; 2006 Jun; 26(3):769-80. PubMed ID: 16834633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.